Annual Accounts Payable
$8.25 M
+$347.00 K+4.39%
December 31, 2023
Summary
- As of February 8, 2025, KNSA annual accounts payable is $8.25 million, with the most recent change of +$347.00 thousand (+4.39%) on December 31, 2023.
- During the last 3 years, KNSA annual accounts payable has risen by +$7.74 million (+1539.36%).
- KNSA annual accounts payable is now -24.47% below its all-time high of $10.92 million, reached on December 31, 2018.
Performance
KNSA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.33 M
+$935.00 K+12.65%
September 30, 2024
Summary
- As of February 8, 2025, KNSA quarterly accounts payable is $8.33 million, with the most recent change of +$935.00 thousand (+12.65%) on September 30, 2024.
- Over the past year, KNSA quarterly accounts payable has increased by +$7.32 million (+722.92%).
- KNSA quarterly accounts payable is now -23.72% below its all-time high of $10.92 million, reached on December 31, 2018.
Performance
KNSA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KNSA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.4% | +722.9% |
| 3 y3 years | +1539.4% | +405.0% |
| 5 y5 years | -24.5% | +29.3% |
KNSA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +341.4% | at high | +1185.2% |
| 5 y | 5-year | at high | +1539.4% | at high | +1555.7% |
| alltime | all time | -24.5% | +3789.6% | -23.7% | +1555.7% |
Kiniksa Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.33 M(+12.6%) |
| Jun 2024 | - | $7.39 M(+31.3%) |
| Mar 2024 | - | $5.63 M(-31.7%) |
| Dec 2023 | $8.25 M(+4.4%) | $8.25 M(+714.8%) |
| Sep 2023 | - | $1.01 M(+56.2%) |
| Jun 2023 | - | $648.00 K(-53.4%) |
| Mar 2023 | - | $1.39 M(-82.4%) |
| Dec 2022 | $7.90 M(+322.9%) | $7.90 M(+437.7%) |
| Sep 2022 | - | $1.47 M(-41.8%) |
| Jun 2022 | - | $2.52 M(-25.5%) |
| Mar 2022 | - | $3.38 M(+81.1%) |
| Dec 2021 | $1.87 M | $1.87 M(+13.3%) |
| Sep 2021 | - | $1.65 M(-60.3%) |
| Jun 2021 | - | $4.16 M(+50.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $2.76 M(+449.3%) |
| Dec 2020 | $503.00 K(-91.2%) | $503.00 K(-87.2%) |
| Sep 2020 | - | $3.92 M(+65.4%) |
| Jun 2020 | - | $2.37 M(-44.5%) |
| Mar 2020 | - | $4.27 M(-24.9%) |
| Dec 2019 | $5.69 M(-47.9%) | $5.69 M(-11.6%) |
| Sep 2019 | - | $6.44 M(-31.0%) |
| Jun 2019 | - | $9.34 M(+35.5%) |
| Mar 2019 | - | $6.89 M(-36.9%) |
| Dec 2018 | $10.92 M(+796.4%) | $10.92 M(+133.9%) |
| Sep 2018 | - | $4.67 M(+732.1%) |
| Jun 2018 | - | $561.00 K(-79.9%) |
| Mar 2018 | - | $2.80 M(+129.6%) |
| Dec 2017 | $1.22 M(+474.5%) | $1.22 M |
| Dec 2016 | $212.00 K | - |
FAQ
- What is Kiniksa Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual accounts payable year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly accounts payable year-on-year change?
What is Kiniksa Pharmaceuticals annual accounts payable?
The current annual accounts payable of KNSA is $8.25 M
What is the all time high annual accounts payable for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual accounts payable is $10.92 M
What is Kiniksa Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, KNSA annual accounts payable has changed by +$347.00 K (+4.39%)
What is Kiniksa Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of KNSA is $8.33 M
What is the all time high quarterly accounts payable for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly accounts payable is $10.92 M
What is Kiniksa Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, KNSA quarterly accounts payable has changed by +$7.32 M (+722.92%)